Keros Therapeutics, Inc. (KROS)

12.07 +0.43 (+3.69%) USD  |  NASDAQ  |  May 08, 16:00
12.06 -0.02 (-0.12%) Pre-Market: 20:00
More

Keros Therapeutics Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
United Therapeutics Corp. Upgrade
Opus Genetics, Inc. Upgrade